Drug discovery is shifting from hypothesis-first to simulation-first. Foundation models simulate perturbations, prioritize targets, reduce experimental waste, and validate strategically.
The Simulation-First Transition
Legacy model
Wet lab → iterate → screen → validate → repeat
Emerging model
Representation learning → perturbation simulation → prioritization → experimental validation
Multi-Omics Intelligence Layer
| Integrated datasets | Structured outputs |
|---|---|
| Bulk RNA-seq, Single-cell RNA-seq, ATAC-seq, CRISPR screens, Chemical perturbation, Proteomics | Cell-type representations, Embedding spaces, Feature stores, Versioned releases |
Gene and Chemical Embedding Architecture
Foundation Model Support Layer
We prepare biological datasets for foundation model pretraining, contrastive learning, perturbation modeling, and large-scale representation learning.
LLM-Driven Biomedical Structuring
| LLM capabilities | Agentic monitoring |
|---|---|
| Ontology mapping, CRISPR classification, Metadata harmonization, Publication parsing | Ontology drift detection, Schema alignment, Inconsistency flagging, Version coherence |
Agentic Discovery Infrastructure
Governance and Stability Layer
| Failure risks | Controls enforced |
|---|---|
| Metadata shifts, Distribution drift, Embedding degradation | Release gates, Drift thresholds, Version manifests, Sub-cohort monitoring |
Strategic positioning
Foundation model companies in biology are scaling rapidly. Without structured multi-omics corpora, ontology alignment, cross-modal harmonization, and governance infrastructure, models overfit noise and performance degrades silently.
Trinzz builds the biological operating layer beneath simulation-first drug discovery. We partner with frontier AI labs and translational pharma teams operating at foundation-model scale.